Invesaro

Stocks Health care MD

NYSE · Health care

Pediatrix Medical Group, Inc. (MD)

Pediatrix Medical Group, Inc. brought in $2B of revenue over the twelve months to June 30, 2026, up 0.5% from a year earlier. Net income was $174.8M, a net margin of 9.0%. At June 30, 2026 it held $288.9M in cash against $584.2M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 4, 2026.

Price
$26.31
+2.53% on the day · September 25, 2026
52-week range $15.70 to $27.94
Market cap
$2.1B
Revenue (last 12 months)
$2B
+0.5% year on year
Net margin
9.0%
P/E
13.6
on FY2025 diluted EPS

What Pediatrix Medical Group, Inc. does

Pediatrix Medical Group, Inc. is registered with the SEC under industry code SIC 8060 (Services-Hospitals). Its shares trade on NYSE under the ticker MD.

Revenue and profit by year

Revenue
FY18: $1.7B $1.7B FY18FY19: $1.8B $1.8B FY19FY20: $1.7B $1.7B FY20FY21: $1.9B $1.9B FY21FY22: $2B $2B FY22FY23: $2B $2B FY23FY24: $2B $2B FY24FY25: $1.9B $1.9B FY25
Net income
FY18: $268.6M $268.6M FY18FY19: -$1.5B -$1.5B FY19FY20: -$796.5M -$796.5M FY20FY21: $131M $131M FY21FY22: $66.3M $66.3M FY22FY23: -$60.4M -$60.4M FY23FY24: -$99.1M -$99.1M FY24FY25: $165.4M $165.4M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$1.9B$208.8M$165.4M$1.94n/a
2024$2B-$68.7M-$99.1M-$1.19n/a
2023$2B$7.3M-$60.4M-$0.73n/a
2022$2B$172.7M$66.3M$0.79n/a
2021$1.9B$202.9M$131M$1.53n/a
2020$1.7B$98.1M-$796.5M-$9.55n/a
Next report expected around November 2, 2026.

Estimated from its filing rhythm: 52 weeks after its report of November 3, 2025. Not a date the company has announced. See the report calendar

Where MD ranks in Health care

Revenue$1.9B
#113 of 523 in Health care · Top 21%
Revenue growth-4.9%
#378 of 437 in Health care · Bottom 14%
Net margin8.6%
#107 of 447 in Health care · Top 24%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Pediatrix Medical Group, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 3, 2026
  2. September 3, 2026
  3. September 3, 2026
  4. August 4, 2026
    Quarterly report 10-Q · period to June 30, 2026
  5. August 4, 2026
  6. July 24, 2026
  7. July 15, 2026
  8. July 14, 2026
  9. May 21, 2026
  10. May 7, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 14, 2026. Insider transactions on SEC

Insider trades

What the people running Pediatrix Medical Group, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider bought or sold shares on the open market in the last 90 days. The 1 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
September 10, 2026 Linynsky Laura ADirector Other change 6,000 $26.82 $160.9K Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

All filings on SEC EDGAR

Questions about MD

What does Pediatrix Medical Group, Inc. do?

Pediatrix Medical Group, Inc. is registered with the SEC under industry code SIC 8060 (Services-Hospitals). Its shares trade on NYSE under the ticker MD.

Is Pediatrix Medical Group, Inc. profitable?

Yes. Over the twelve months to June 30, 2026 it reported net income of $174.8M on revenue of $2B, a net margin of 9.0%.

How much revenue does Pediatrix Medical Group, Inc. make?

Over the twelve months to June 30, 2026 Pediatrix Medical Group, Inc. reported revenue of $2B. That is 0.5% more than a year earlier.

When did Pediatrix Medical Group, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 4, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the planned insider sale from September 14, 2026.

Similar companies

Compare MD with

Compare MD with any company

Follow MD

Get an email when Pediatrix Medical Group, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow MD: get an email when it files

Where the numbers come from

Financial figures are the values Pediatrix Medical Group, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.